TherapeuticsMD
TXMD
TXMD
144 hedge funds and large institutions have $982M invested in TherapeuticsMD in 2017 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 34 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
+10
Holders Change %
+7.46%
% of All Funds
3.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
49
Reduced
34
Closed
20
Calls
$2.71M
Puts
$7.26M
Net Calls
-$4.55M
Net Calls Change
-$4.18M
Top Buyers
| 1 |
BlackRock
New York
|
+$20M |
| 2 |
Bank of New York Mellon
New York
|
+$18.7M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$10.8M |
| 4 |
First Eagle Investment Management
New York
|
+$9.47M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
+$6.19M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$37M |
| 2 |
JPMorgan Chase & Co
New York
|
-$14.4M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$13.4M |
| 4 |
CCI
Columbus Circle Investors
|
-$10.7M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$3.49M |
